Walleye Trading LLC Madrigal Pharmaceuticals, Inc. Put Options Transaction History

Walleye Trading LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$171.37 - $283.23 $291,329 - $481,491	-1,700 Reduced 68.0%	800 $213,000
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $228,760 - $450,547	1,900 Added 316.67%	2,500 $578,000
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $14,604 - $22,578	100 Added 20.0%	600 $87,000
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $40,776 - $62,400	200 Added 66.67%	500 $115,000
Q1 2023 May 15, 2023	SELL	$231.06 - $307.08 $1.34 Million - $1.78 Million	-5,800 Reduced 95.08%	300 $72,000
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $4.92 Million - $25 Million	-84,300 Reduced 93.25%	6,100 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $5 Million - $6.57 Million	82,600 Added 1058.97%	90,400 $5.88 Million
Q2 2022 Aug 08, 2022	BUY	$58.04 - $100.2 $412,084 - $711,420	7,100 Added 1014.29%	7,800 $558,000
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $39,123 - $71,323	700 New	700 $69,000
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $1.84 Million - $2.23 Million	-16,700 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.78 - $124.21 $1.38 Million - $1.71 Million	13,800 Added 475.86%	16,700 $1.98 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $174,377 - $364,559	2,900 New	2,900 $328,000
Q1 2020 May 15, 2020	SELL	$66.76 - $93.49 $166,900 - $233,725	-2,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$84.28 - $118.5 $42,140 - $59,250	500 Added 25.0%	2,500 $228,000
Q1 2019 May 15, 2019	BUY	$103.48 - $143.84 $206,960 - $287,680	2,000 New	2,000 $251,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.